The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schaffer Michael I since 2014.
This trader's CIK number is 1250730.
At the time of last reporting, Schaffer Michael I was the VP of Laboratory Operations of Psychemedics Corp. (stock ticker symbol PMD).
Also see all insider trading activities at Psychemedics Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PMD | 100 | $495 | 0 | $0 | 0 | $0 |
| 2020 | PMD | 500 | $2,100 | 0 | $0 | 0 | $0 |
| 2019 | PMD | 0 | $0 | 9,331 | $90,867 | 0 | $0 |
| 2018 | PMD | 0 | $0 | 6,324 | $121,610 | 0 | $0 |
| 2017 | PMD | 0 | $0 | 7,548 | $154,028 | 0 | $0 |
| 2016 | PMD | 4,507 | $49,982 | 0 | $0 | 0 | $0 |
| 2015 | PMD | 0 | $0 | 2,837 | $41,489 | 0 | $0 |
| 2014 | PMD | 0 | $0 | 0 | $0 | 19,600 | $274,440 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-16 | PMD | Buy | 100 | 4.95 | 495 |
| 2020-11-18 | PMD | Buy | 500 | 4.20 | 2,100 |
| 2019-06-14 | PMD | Sale | 3,900 | 9.61 | 37,479 |
| 2019-06-12 | PMD | Sale | 2,800 | 9.84 | 27,552 |
| 2019-06-13 | PMD | Sale | 2,631 | 9.82 | 25,836 |
| 2018-09-06 | PMD | Sale | 6,324 | 19.23 | 121,610 |
| 2017-09-01 | PMD | Sale | 981 | 21.16 | 20,757 |
| 2017-09-05 | PMD | Sale | 4,400 | 20.37 | 89,628 |
| 2017-09-06 | PMD | Sale | 2,167 | 20.14 | 43,643 |
| 2016-02-16 | PMD | Buy | 4,507 | 11.09 | 49,982 |
| 2015-06-15 | PMD | Sale | 1,601 | 14.61 | 23,382 |
| 2015-06-16 | PMD | Sale | 1,236 | 14.65 | 18,107 |
| 2014-03-10 | PMD | Option Ex | 16,600 | 14.40 | 239,040 |
| 2014-02-11 | PMD | Option Ex | 3,000 | 11.80 | 35,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schaffer Michael I (VP of Laboratory Operations of Psychemedics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.